• Education
    • Higher Education
    • Scholarships & Grants
    • Online Learning
    • School Reforms
    • Research & Innovation
  • Lifestyle
    • Travel
    • Food & Drink
    • Fashion & Beauty
    • Home & Living
    • Relationships & Family
  • Technology & Startups
    • Software & Apps
    • Startup Success Stories
    • Startups & Innovations
    • Tech Regulations
    • Venture Capital
    • Artificial Intelligence
    • Cybersecurity
    • Emerging Technologies
    • Gadgets & Devices
    • Industry Analysis
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy
Today Headline
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
Today Headline
No Result
View All Result
Home Science & Environment Medical Research

As prevention strategy for sexually transmitted infections rolls out, experts highlight both promise and knowledge gaps

January 7, 2025
in Medical Research
Reading Time: 4 mins read
A A
0
As prevention strategy for sexually transmitted infections rolls out, experts highlight both promise and knowledge gaps
8
SHARES
17
VIEWS
Share on FacebookShare on Twitter


As prevention strategy for sexually transmitted infections rolls out, experts highlight both promise and knowledge gaps
Illustration depicting a chlamydia-infected cell. Chlamydia trachomatis bacteria (represented by small dark spherical shapes colorized blue) undergo development within a membrane-enclosed “inclusion body.” The dark green shape on the right of the cell denotes the nucleus. Credit: NIAID

As health care services begin offering doxycycline to prevent bacterial sexually transmitted infections (STIs), real-world evidence demonstrates that the postexposure strategy, called doxy PEP, is reducing the rate of syphilis and chlamydia, but has had little to no effect on gonorrhea and needs close monitoring for signals of antibiotic resistance.

JAMA Internal Medicine has published two reports of early results of doxy PEP rollout in California. Encouraging signals and remaining scientific questions from those reports are highlighted in an accompanying commentary by Jeanne Marrazzo, M.D., M.P.H., director of the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID), and Jodie Dionne, M.D., M.P.H., associate professor of medicine in the Division of Infectious Diseases and associate professor of obstetrics and gynecology in the Division of Maternal-Fetal Medicine at the University of Alabama at Birmingham.

“These reports are part of the crucial scientific process of translating clinical research to implementation at scale,” said Dr. Marrazzo. “Doxy PEP is proving to be an important intervention in our effort to decrease STI incidence while we continue to invest in research to develop safe and effective preventive vaccines and next-generation antibiotics.”

The Centers for Disease Control and Prevention (CDC) reported more than 2.4 million cases of syphilis, gonorrhea, and chlamydia in the United States in 2023, including 3,882 cases of congenital syphilis, of which 279 resulted in stillbirths and infant deaths. While the latest data show signs the STI epidemic might be slowing, case counts are still 90% higher than 2004 levels and present a threat to peoples’ health.

Taking oral doxycycline within 72 hours of condomless sex reduced the incidence of the bacterial STIs syphilis, chlamydia and gonorrhea by two-thirds among gay, bisexual, and other men who have sex with men and transgender women in a recent randomized controlled trial. However, the antibiotic had no preventive effect in a similar study in cisgender women. Based on this evidence, the CDC recommends that U.S. health care providers discuss doxy PEP with men who have sex with men and transgender women who have a history of at least one bacterial STI.

In one of the new published analyses, public health surveillance data from selected public clinics in San Francisco showed that cases of early syphilis and chlamydia in men who have sex with men and transgender women decreased by 50% and 51%, respectively, after 13 months of targeted doxy PEP implementation, but gonorrhea incidence increased by 26% in the same time period.

In the other analysis, pharmacy prescription data from an integrated health system in California showed that after 12 months of doxy PEP rollout in people assigned male sex at birth who were also taking HIV pre-exposure prophylaxis, STI positivity rates declined by 79%, 80%, and 12% for chlamydia, syphilis, and gonorrhea, respectively. The declines in gonorrhea were limited to infections at the urethra and rectum. No declines were seen at the pharynx (throat), a common site where people acquire gonorrhea.

In their commentary, Drs. Marrazzo and Dionne celebrated doxy PEP’s substantial effect on chlamydia and syphilis in routine health service settings. They cautioned that the mixed results on gonorrhea, along with results from another recent study showing people taking doxy PEP had some evidence of resistance to a class of antibiotics for gonorrhea treatment, point to the need to closely track the development of antimicrobial resistance in the context of doxy PEP use and to include measures of drug resistance in all doxy PEP studies. They also noted some disparities in doxy PEP uptake and the need to ensure equitable knowledge, acceptability, and access as the rollout continues.

Reflecting on ongoing research needs, Drs. Marrazzo and Dionne pointed to the persistent gaps in doxy PEP evidence for cisgender women. They called for research to better understand the relationship between doxycycline dosing frequency and its preventive efficacy in real-world settings, as well as the durability of doxy PEP’s protective effects.

Finally, they highlighted broader STI intervention needs, including safe and effective vaccines and new antibiotics for all people affected by STIs.

More information:
Madeline Sankaran et al, Doxycycline Postexposure Prophylaxis and Sexually Transmitted Infection Trends, JAMA Internal Medicine (2025). DOI: 10.1001/jamainternmed.2024.7178

Commentary: Jeanne M. Marrazzo et al, DoxyPEP to Prevent Bacterial STIs—Ready for Prime Time?, JAMA Internal Medicine (2025). DOI: 10.1001/jamainternmed.2024.7165

Provided by
NIH/National Institute of Allergy and Infectious Diseases


Citation:
As prevention strategy for sexually transmitted infections rolls out, experts highlight both promise and knowledge gaps (2025, January 7)
retrieved 7 January 2025
from https://medicalxpress.com/news/2025-01-strategy-sexually-transmitted-infections-experts.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.



As prevention strategy for sexually transmitted infections rolls out, experts highlight both promise and knowledge gaps
Illustration depicting a chlamydia-infected cell. Chlamydia trachomatis bacteria (represented by small dark spherical shapes colorized blue) undergo development within a membrane-enclosed “inclusion body.” The dark green shape on the right of the cell denotes the nucleus. Credit: NIAID

As health care services begin offering doxycycline to prevent bacterial sexually transmitted infections (STIs), real-world evidence demonstrates that the postexposure strategy, called doxy PEP, is reducing the rate of syphilis and chlamydia, but has had little to no effect on gonorrhea and needs close monitoring for signals of antibiotic resistance.

JAMA Internal Medicine has published two reports of early results of doxy PEP rollout in California. Encouraging signals and remaining scientific questions from those reports are highlighted in an accompanying commentary by Jeanne Marrazzo, M.D., M.P.H., director of the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID), and Jodie Dionne, M.D., M.P.H., associate professor of medicine in the Division of Infectious Diseases and associate professor of obstetrics and gynecology in the Division of Maternal-Fetal Medicine at the University of Alabama at Birmingham.

“These reports are part of the crucial scientific process of translating clinical research to implementation at scale,” said Dr. Marrazzo. “Doxy PEP is proving to be an important intervention in our effort to decrease STI incidence while we continue to invest in research to develop safe and effective preventive vaccines and next-generation antibiotics.”

The Centers for Disease Control and Prevention (CDC) reported more than 2.4 million cases of syphilis, gonorrhea, and chlamydia in the United States in 2023, including 3,882 cases of congenital syphilis, of which 279 resulted in stillbirths and infant deaths. While the latest data show signs the STI epidemic might be slowing, case counts are still 90% higher than 2004 levels and present a threat to peoples’ health.

Taking oral doxycycline within 72 hours of condomless sex reduced the incidence of the bacterial STIs syphilis, chlamydia and gonorrhea by two-thirds among gay, bisexual, and other men who have sex with men and transgender women in a recent randomized controlled trial. However, the antibiotic had no preventive effect in a similar study in cisgender women. Based on this evidence, the CDC recommends that U.S. health care providers discuss doxy PEP with men who have sex with men and transgender women who have a history of at least one bacterial STI.

In one of the new published analyses, public health surveillance data from selected public clinics in San Francisco showed that cases of early syphilis and chlamydia in men who have sex with men and transgender women decreased by 50% and 51%, respectively, after 13 months of targeted doxy PEP implementation, but gonorrhea incidence increased by 26% in the same time period.

In the other analysis, pharmacy prescription data from an integrated health system in California showed that after 12 months of doxy PEP rollout in people assigned male sex at birth who were also taking HIV pre-exposure prophylaxis, STI positivity rates declined by 79%, 80%, and 12% for chlamydia, syphilis, and gonorrhea, respectively. The declines in gonorrhea were limited to infections at the urethra and rectum. No declines were seen at the pharynx (throat), a common site where people acquire gonorrhea.

In their commentary, Drs. Marrazzo and Dionne celebrated doxy PEP’s substantial effect on chlamydia and syphilis in routine health service settings. They cautioned that the mixed results on gonorrhea, along with results from another recent study showing people taking doxy PEP had some evidence of resistance to a class of antibiotics for gonorrhea treatment, point to the need to closely track the development of antimicrobial resistance in the context of doxy PEP use and to include measures of drug resistance in all doxy PEP studies. They also noted some disparities in doxy PEP uptake and the need to ensure equitable knowledge, acceptability, and access as the rollout continues.

Reflecting on ongoing research needs, Drs. Marrazzo and Dionne pointed to the persistent gaps in doxy PEP evidence for cisgender women. They called for research to better understand the relationship between doxycycline dosing frequency and its preventive efficacy in real-world settings, as well as the durability of doxy PEP’s protective effects.

Finally, they highlighted broader STI intervention needs, including safe and effective vaccines and new antibiotics for all people affected by STIs.

More information:
Madeline Sankaran et al, Doxycycline Postexposure Prophylaxis and Sexually Transmitted Infection Trends, JAMA Internal Medicine (2025). DOI: 10.1001/jamainternmed.2024.7178

Commentary: Jeanne M. Marrazzo et al, DoxyPEP to Prevent Bacterial STIs—Ready for Prime Time?, JAMA Internal Medicine (2025). DOI: 10.1001/jamainternmed.2024.7165

Provided by
NIH/National Institute of Allergy and Infectious Diseases


Citation:
As prevention strategy for sexually transmitted infections rolls out, experts highlight both promise and knowledge gaps (2025, January 7)
retrieved 7 January 2025
from https://medicalxpress.com/news/2025-01-strategy-sexually-transmitted-infections-experts.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.


Tags: Health ResearchHealth Research NewsHealth ScienceMedicine ResearchMedicine Research NewsMedicine Science
Previous Post

Man accused of burning woman to death on a subway train is set to be arraigned

Next Post

On a Wild Mouse Chase to Understand Parenting, Love, and Fear todayheadline

Related Posts

CAR T cell therapy

Dual-target CAR T cell therapy slows growth of aggressive brain cancer

June 1, 2025
3
prostate cancer

Clinical trial shows biomarkers hold clue in treating aggressive prostate cancer

June 1, 2025
5
Next Post
Felix Baier samples wild individuals of various subspecies of Peromyscus maniculatus on a rocky shore.

On a Wild Mouse Chase to Understand Parenting, Love, and Fear todayheadline

  • Trending
  • Comments
  • Latest
Family calls for change after B.C. nurse dies by suicide after attacks on the job

Family calls for change after B.C. nurse dies by suicide after attacks on the job

April 2, 2025
Pioneering 3D printing project shares successes

Product reduces TPH levels to non-hazardous status

November 27, 2024

Hospital Mergers Fail to Deliver Better Care or Lower Costs, Study Finds todayheadline

December 31, 2024

Police ID man who died after Corso Italia fight

December 23, 2024
Harris tells supporters 'never give up' and urges peaceful transfer of power

Harris tells supporters ‘never give up’ and urges peaceful transfer of power

0
Des Moines Man Accused Of Shooting Ex-Girlfriend's Mother

Des Moines Man Accused Of Shooting Ex-Girlfriend’s Mother

0

Trump ‘looks forward’ to White House meeting with Biden

0
Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

0
petition button resized 3

Petition: Stop the Helicopter Killings of Koalas in Victoria, Australia

June 1, 2025
CAR T cell therapy

Dual-target CAR T cell therapy slows growth of aggressive brain cancer

June 1, 2025
What to know as Trump administration targets international students with visa restrictions, arrests

What to know as Trump administration targets international students with visa restrictions, arrests

June 1, 2025
How the Department of Government Efficiency cut wasteful spending on immigration

How the Department of Government Efficiency cut wasteful spending on immigration

June 1, 2025

Recent News

petition button resized 3

Petition: Stop the Helicopter Killings of Koalas in Victoria, Australia

June 1, 2025
2
CAR T cell therapy

Dual-target CAR T cell therapy slows growth of aggressive brain cancer

June 1, 2025
3
What to know as Trump administration targets international students with visa restrictions, arrests

What to know as Trump administration targets international students with visa restrictions, arrests

June 1, 2025
4
How the Department of Government Efficiency cut wasteful spending on immigration

How the Department of Government Efficiency cut wasteful spending on immigration

June 1, 2025
6

TodayHeadline is a dynamic news website dedicated to delivering up-to-date and comprehensive news coverage from around the globe.

Follow Us

Browse by Category

  • Africa
  • Asia
  • Basketball
  • Business & Finance
  • Climate Change
  • Crime & Justice
  • Cybersecurity
  • Economic Policies
  • Elections
  • Entertainment
  • Entrepreneurship
  • Environmental Policies
  • Europe
  • Football
  • Gadgets & Devices
  • Health
  • Medical Research
  • Mental Health
  • Middle East
  • Motorsport
  • Olympics
  • Politics
  • Public Health
  • Relationships & Family
  • Science & Environment
  • Software & Apps
  • Space Exploration
  • Sports
  • Stock Market
  • Technology & Startups
  • Tennis
  • Travel
  • Uncategorized
  • Us & Canada
  • Wildlife & Conservation
  • World News

Recent News

petition button resized 3

Petition: Stop the Helicopter Killings of Koalas in Victoria, Australia

June 1, 2025
CAR T cell therapy

Dual-target CAR T cell therapy slows growth of aggressive brain cancer

June 1, 2025
  • Education
  • Lifestyle
  • Technology & Startups
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy

© 2024 Todayheadline.co

Welcome Back!

OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Business & Finance
  • Corporate News
  • Economic Policies
  • Entrepreneurship
  • Market Trends
  • Crime & Justice
  • Court Cases
  • Criminal Investigations
  • Cybercrime
  • Legal Reforms
  • Policing
  • Education
  • Higher Education
  • Online Learning
  • Entertainment
  • Awards & Festivals
  • Celebrity News
  • Movies
  • Music
  • Health
  • Fitness & Nutrition
  • Medical Breakthroughs
  • Mental Health
  • Pandemic Updates
  • Lifestyle
  • Fashion & Beauty
  • Food & Drink
  • Home & Living
  • Politics
  • Elections
  • Government Policies
  • International Relations
  • Legislative News
  • Political Parties
  • Africa
  • Asia
  • Europe
  • Middle East
  • Artificial Intelligence
  • Cybersecurity
  • Emerging Technologies
  • Gadgets & Devices
  • Industry Analysis
  • Basketball
  • Football
  • Motorsport
  • Olympics
  • Climate Change
  • Environmental Policies
  • Medical Research
  • Science & Environment
  • Space Exploration
  • Wildlife & Conservation
  • Sports
  • Tennis
  • Technology & Startups
  • Software & Apps
  • Startup Success Stories
  • Startups & Innovations
  • Tech Regulations
  • Venture Capital
  • Uncategorized
  • World News
  • Us & Canada
  • Public Health
  • Relationships & Family
  • Travel
  • Research & Innovation
  • Scholarships & Grants
  • School Reforms
  • Stock Market
  • TV & Streaming
  • Advertise with Us
  • Privacy & Policy
  • About us
  • Contact

© 2024 Todayheadline.co